We found that the expression of SFRP2/3/4 was higher in gastric adenocarcinoma of not otherwise specified (NOS) and diffuse type, and gastric intestinal adenocarcinoma of mucinous type. The gene discussed is SFRP2; the disease is gastric intestinal type adenocarcinoma.